Skip to content
Biodatica
Start free

Investigator

Nadia R Roan

J. DAVID GLADSTONE INSTITUTES · funded by NIAID, NIDDK

Companies
4

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$3.5M

Summed across those awards.

First award
Jul 15, 2022

Latest Aug 6, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Targeting CD127-expressing tissue reservoir cells as a strategy for HIV cure

    $252k

    Aug 6, 2024NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11162463 (opens the source filing in a new tab)

  2. R01

    Targeting the transcriptionally-active reservoir to reduce chronic inflammation in aged people with HIV

    $891k

    Mar 1, 2024NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11043399 (opens the source filing in a new tab)

  3. R01

    Targeting the transcriptionally-active reservoir to reduce chronic inflammation in aged people with HIV

    $890k

    Mar 1, 2024NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11320733 (opens the source filing in a new tab)

  4. R01

    Multiomics characterization, induction, and elimination of the HIV gut reservoir

    $724k

    Jul 15, 2022NIDDKJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11086092 (opens the source filing in a new tab)

  5. R01

    Multiomics characterization, induction, and elimination of the HIV gut reservoir

    $758k

    Jul 15, 2022NIDDKJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11325760 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources